Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.

Biotechnology

Mammoth Biosciences

Mammoth Biosciences' headquarters in Brisbane, CA, United States

This department focuses on conducting research and providing analytical support to drive informed decision-making.

Research and Analysis

The Research and Development team at Mammoth Biosciences focuses on discovering and developing novel CRISPR systems to expand the company's next-generation genomics platform. This team conducts cutting-edge research to enhance diagnostics and genome editing applications, collaborating across various projects in life science research, healthcare, agriculture, and biodefense. Their work involves extensive experimentation, protein engineering, and automation to create advanced and accessible CRISPR-based solutions for improving disease detection and genetic manipulation.

Research and Development

This department conducts innovative research and scientific analysis to advance knowledge and solutions in the field.

Research Science

The Leadership Team at Mammoth Biosciences is responsible for setting the strategic vision and direction of the company, ensuring alignment between innovative research and operational goals. This team, comprised of co-founders and key executives with deep expertise in science, technology, and business, drives the development of next-generation CRISPR products while fostering partnerships and securing funding to advance the company’s mission of democratizing disease detection and enhancing genome editing capabilities. Through collaborative leadership, they aim to navigate the complexities of the biotech landscape to deliver impactful solutions in healthcare and beyond.

Leadership Team

The Legal and Corporate Governance team at Mammoth Biosciences is responsible for overseeing the company's legal compliance, intellectual property management, and corporate governance practices. This includes providing legal advice, protecting the company's CRISPR-related innovations through IP rights, and ensuring that the board and executive actions align with legal and regulatory standards to maintain ethical and effective corporate operations.

Legal and Corporate Governance

The Scientific and Technical Advisory Team at Mammoth Biosciences provides strategic guidance on the development and application of novel CRISPR systems. Comprised of distinguished experts and co-founders, the team advises on scientific research, technical challenges, and innovation strategies to enhance the company's diagnostics and genome editing technologies.

��

People (7)

Jobs (0)

Other teams

Research and Development

Research Science

Leadership Team

Legal and Corporate Governance

Scientific and Technical Advisory Team

��������

People (7)

Jobs (0)

Other teams

Research and Development

Research Science

Leadership Team

Legal and Corporate Governance

Scientific and Technical Advisory Team

��